ASSEMBLY BIOSCIENCES, INC. - Form 4 Filing Summary

This Form 4 filing details transactions by Anuj Gaggar, Chief Medical Officer of ASSEMBLY BIOSCIENCES, INC. On March 29, 2026, Gaggar acquired 14,000 shares of Common Stock with a transaction value of $0. This acquisition was part of an annual equity grant approved on March 29, 2026, contingent upon stockholder approval of an amendment to the Issuer's 2018 Stock Incentive Plan. The RSUs associated with this grant will vest in four installments on March 29, 2027, 2028, 2029, and 2030, provided continuous service. Additionally, the filing notes 688 shares acquired under the Employee Stock Purchase Plan on May 14, 2026. Following these transactions, Gaggar owns 42,688 shares.